載入...
The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
In the past two decades, there has been a significant improvement in the understanding of the molecular pathogenesis of Renal Cell Carcinoma (RCC). These insights in the biological pathways have resulted in the development of multiple agents targeting vascular endothelial growth factor (VEGF), as we...
Na minha lista:
| 發表在: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7017064/ https://ncbi.nlm.nih.gov/pubmed/31936065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010143 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|